… anti-inflammatory drugs; PMR: polymyalgia rheumatica; RS3PE… tenosynovitis of the biceps
in a patient with PMR. The one on … in a patient with polymyalgia rheumatica. Ultrasonographic …

… We think that tocilizumab or any other anti-IL-6 agent may become the drug of choice in
refractory patients in the near future. However, CRP and other acute phase proteins of …

… of patients with PMR as relapses do occur and patients with … disease-modifying antirheumatic
drugs and biologics as GC … (PET CT) findings in patients with polymyalgia rheumatica. (a) …

… -term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids. …
, 3 ,4 and musculoskeletal symptoms were treated with nonsteroidal anti-inflammatory drugs (…

… , and drug therapy (including dose and duration of CS among patients receiving steroids, and
… Patients with PMR were categorized into the following 3 groups: 1) those who were treated …

… The effectiveness of biological therapies, such as anti-interleukin 6, in patients with
polymyalgia rheumatica that is refractory to glucocorticoids requires further investigation. Most …

… Although polymyalgia rheumatica does not clearly impair survival or organ function, it can
have a … Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis. …

… These criteria should be applied to patients aged 50 years and older, with bilateral shoulder
… To classify a patient as having polymyalgia rheumatica, a score of 4 is needed in the …

… Although myalgias are prominent symptoms in patients with polymyalgia rheumatica,
muscle inflammation is not typically seen. In a study from 2010, however, increased …

… polymyalgia rheumatica clinical findings in five patients as … a group of patients with
polymyalgia rheumatica articular … are the drug of choice to treat polymyalgia rheumatica. An initial …